Methoxamine
Not to be confused with methoxetamine.
![]() | |
Systematic (IUPAC) name | |
---|---|
2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous, intramuscular, oral. |
Pharmacokinetic data | |
Bioavailability | 21% (oral), 93% (I.M). |
Biological half-life | 18.6 hours |
Excretion | renal |
Identifiers | |
CAS Number |
390-28-3 ![]() |
ATC code | C01CA10 (WHO) |
PubChem | CID 6082 |
IUPHAR/BPS | 483 |
DrugBank |
DB00723 ![]() |
ChemSpider |
5857 ![]() |
UNII |
HUQ1KC1YLI ![]() |
KEGG |
D08201 ![]() |
ChEMBL |
CHEMBL524 ![]() |
Chemical data | |
Formula | C11H17NO3 |
Molar mass | 211.258 |
| |
| |
![]() ![]() |
Methoxamine is an α1-adrenergic receptor agonist,[1] similar in structure to phenylephrine and 2,5-DMA. It was developed by Burroughs-Wellcome in the 1940s.[2] The drug induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.
See also
References
|
|
|
|
This article is issued from Wikipedia - version of the Monday, April 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.